Foreign hospital groups often enter Saudi Arabia by taking a stake in an existing facility, while relying on a local partner structure to accelerate execution. Aster DM Healthcare’s move in the Eastern Province follows that playbook. The company acquired a majority stake in ProCare Hospital through a joint venture with Abdulrahman Saleh Al Rajhi and Partners Co. Group, and the hospital will be rebranded as Aster ProCare Hospital. This Aster Procare Saudi stake is positioned as more than a name change. It is designed to plug ProCare into Aster’s integrated model spanning hospitals, clinics, pharmacies, and digital health solutions, including the myAster platform.
The operational headline is capacity. Multiple reports state that, after the transaction, Aster’s total bed capacity in Saudi Arabia moves beyond 500 beds. The immediate addition called out is 109 beds linked to ProCare in the Eastern Province, and Aster has also signaled a planned build-out that turns ProCare from a 100-bed hospital into a 209-bed asset. Those numbers matter because the upgrade changes the clinical mix and cost base. Coverage requirements rise as higher-acuity services expand, including more cardiology, cath lab work, and critical care, alongside tighter nursing ratios and more exposure to Saudi reimbursement dynamics.
Why Minority-Style Positions Still Matter in Majority-Control Deals
Even when a foreign group takes majority control, the entry logic can resemble a minority-position strategy: share the platform with a local partner, then scale. ProCare Hospital was founded in 2009 and is described as a joint venture tied to Abdulrahman Saleh Al Rajhi and Partners Co Group. No financial details were disclosed for the new transaction, but the structure is explicit: a joint venture was used to complete the acquisition. In practice, this kind of stake-led entry shifts the early focus away from greenfield risk and toward integration, recruitment, and utilisation—especially as Aster seeks to expand capacity without discounting to fill beds.
The ProCare deal also sits inside a longer Saudi trajectory for Aster. Gulf Business reports the group first entered the Saudi market in 2011 through Aster Sanad Hospital in Riyadh and has expanded since then. AGBI adds that in November 2024, Aster’s group CEO Alisha Moopen said the company planned to increase its roster of 250 hospital beds in Riyadh to 1,000 within the next three to four years. Together, the Riyadh scaling ambition and the Eastern Province acquisition show how a stake in an operating hospital can be paired with multi-site growth plans rather than treated as a standalone asset.
Finally, the broader regional pattern reinforces why Saudi Arabia draws this type of investment structure. Zavis notes that NMC Health entered Saudi Arabia through a 70% stake in As Salama Hospital in Al Khobar in 2016. The same analysis flags how Gulf providers watch each other’s cross-border moves as capacity, pricing, and staffing pressures shift between markets. Zavis also references a separate context figure: Nova One Advisor projects the UAE digital health market will rise from $3.2bn in 2024 to $27.0bn in 2034, underlining why Aster is emphasizing digital rollout alongside bed growth in Saudi Arabia.
What changed in Saudi capacity after Aster took its ProCare Hospital stake?
How was the ProCare acquisition structured?
When did Aster first enter the Saudi market, and how does this deal build on it?
What is one example of another hospital group entering Saudi Arabia through a stake model?
What does Aster’s Saudi ProCare stake signal about digital health priorities?
Talk to us for your needs in:
-
Due Diligence and Valuation Services
-
M&A Strategy and Advisory
-
Post-Merger Integration Management
-
Regulatory and Compliance Advisory
-
Market Entry and Expansion Consulting
-
Investment and Financial Analysis
-
In-Depth Market Survey for M&A
-
Market Intelligence and Insights in M&A
-
Feasibility Study and Assessment in M&A
-
Saudi M&A Benchmarking
